New malaria drug offers new hope in Africa
Posted on Mar 6th 2007 2:00PM by Bethany SandersA new drug is set to bring new hope to families across Africa, hopefully cutting malaria deaths dramatically. Malaria sickens 500 million people each year and takes the lives of 1 million of those, most of them children. But the new drug, developed by drug manufacturer Sanofi-Aventis in conjunction with the Drugs for Neglected Diseases Initiative, eliminates a few of the hurdles of treating this disease.
The drug, known as ASAQ, is not patented, meaning it can be manufactured by anyone. This decision also makes the drug much more affordable. It's been formulated in different doses for children, to make administration more precise and efficient. The drug, in combination with pesticide treated bed nets, is a major weapon in the war on malaria, one of the top killers in Africa.
More new drugs are on their way, and it's a good thing. Though ASAQ is the lowest priced, most available drug to date, and though it will be offered at cost to areas struggling with malaria, as well as humanitarian organizations, it's cost still puts it out of reach for many.
The drug, known as ASAQ, is not patented, meaning it can be manufactured by anyone. This decision also makes the drug much more affordable. It's been formulated in different doses for children, to make administration more precise and efficient. The drug, in combination with pesticide treated bed nets, is a major weapon in the war on malaria, one of the top killers in Africa.
More new drugs are on their way, and it's a good thing. Though ASAQ is the lowest priced, most available drug to date, and though it will be offered at cost to areas struggling with malaria, as well as humanitarian organizations, it's cost still puts it out of reach for many.








